Abbott | ABT - Ebit


Abbott reported $1.85B in EBIT for its fiscal quarter ending in March of 2026.





Ebit Change Date
Abbott USD 1.85B 684M Mar/2026
Agilent USD 399M 46M Mar/2026
AtriCure USD 526K 1.96M Mar/2026
Baxter International USD 66M 280.2M Mar/2026
Becton, Dickinson and Co. USD 627M 36M Mar/2026
Bio-Rad Laboratories USD 941.3M 1.36B Dec/2025
Boston Scientific USD 1.05B 190M Mar/2026
Cooper Companies USD -31M 243.8M Mar/2026
Danaher USD 1.34B 158M Mar/2026
Dexcom USD 255.3M 67.7M Mar/2026
Edwards Lifesciences USD 514.7M 144.4M Mar/2026
Globus Medical USD 164M 17.31M Mar/2026
Insulet USD 122M 24.3M Mar/2026
Integra LifeSciences USD 11.47M 54.54M Mar/2026
Intuitive Surgical USD 859.7M 5.6M Mar/2026
J&J USD 6.62B 1.51B Mar/2026
Medtronic USD 2.09B 354M Mar/2026
Merit Medical Systems USD 44.16M 10.04M Mar/2026
Pfizer USD 4.99B 340M Mar/2026
Smith & Nephew USD 440M 50M Dec/2025
Solventum Corp USD 85M 20M Mar/2026
Stryker USD 1.1B 867M Mar/2026
Tandem Diabetes Care USD 8.29M 31.16M Dec/2025
Teleflex USD 37.03M 686K Mar/2026
Terumo JPY 31.45B 12.43B Mar/2026
Thermo Fisher Scientific USD 1.91B 389M Mar/2026
Zimmer Biomet Holdings USD 395.1M 92.2M Mar/2026